GET DAILY SIGNALSAdvanSix (ASIX) Delivers +15% Revenue Growth in Q3 2026 but Faces Margin Challenges
Key Takeaways
- AdvanSix reported third quarter 2026 sales of $431 million, up 15% year over year and above consensus estimates of roughly $426 million.
- GAAP net loss widened to $7.6 million, or ($0.28) per diluted share, compared with a loss of ($0.10) per share a year earlier.
- Adjusted earnings per share (EPS) came in at a loss of $0.24, missing analyst expectations and down from adjusted EPS of $0.08 in the prior-year period.
- Adjusted EBITDA declined about $10 million year over year to $15 million, as higher raw material costs and reduced production output compressed margins.
- Cash flow from operations improved to $48 million, up $21 million, supporting $30 million of free cash flow generation in the quarter.
Earnings Context and Why It Matters
AdvanSix’s third quarter report offers a clear look at how the company is navigating a period of significant input cost inflation. The vertically integrated chemical producer saw strong pricing across its portfolio, which lifted revenue, but rising sulfur and benzene costs and lower production output at key sites eroded profitability. For investors, the report highlights the tension between commercial execution and operational headwinds, as well as the company’s progress on cash generation and cost discipline. The results also matter because they set the tone heading into the fourth quarter and 2027, when management expects tighter ammonium sulfate supply and potential margin normalization as sulfur costs ease.
Reported Results
AdvanSix posted third quarter 2026 sales of $431 million, a 15% increase from $374.5 million in the prior-year period and modestly above consensus expectations of around $426 million. The top-line gain was driven by 17% favorable pricing, partially offset by a 2% decline in volume. Raw material pass-through pricing rose 10%, while market-based pricing improved 7% across all product lines.
Profitability, however, lagged. The company reported a GAAP net loss of $7.6 million, or ($0.28) per diluted share, compared with a net loss of $2.6 million, or ($0.10) per diluted share, a year earlier. Adjusted diluted EPS was a loss of $0.24, down $0.32 from the prior year and below analyst estimates. Adjusted EBITDA fell to $15 million from roughly $25 million in the year-ago quarter, as a $65 million raw material headwind, led by sulfur and benzene, and reduced production output drove unfavorable fixed cost absorption. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Market Reaction and Investor Sentiment
Investor reaction to the report reflected the mixed nature of the results. The revenue beat and improved cash flow were viewed favorably, but the wider-than-expected adjusted EPS loss and margin compression weighed on sentiment. Analysts noted that strong pricing gains were almost entirely offset by raw material inflation, limiting the earnings benefit of the top-line growth. The sequential decline in profitability and cautious commentary about a price-over-raw-material headwind in the fourth quarter added to near-term caution, even as management pointed to improving supply-demand dynamics for ammonium sulfate heading into 2027.
Forward Outlook and Key Factors to Monitor
Looking ahead, management anticipates a year-over-year price-over-raw-material headwind in the fourth quarter. Nylon and Chemical Intermediates pricing is expected to help offset rising raw materials, while sulfur costs remain a meaningful drag on Plant Nutrients, particularly given the stage of the fertilizer season. The Tampa sulfur marker moderated from $705 per long ton in the third quarter to $615 in the fourth-quarter settlement, but there is a lag in realized input pricing.
Investors should monitor several factors in the coming quarters. First, sulfur and benzene cost trends will be central to margin recovery, given that every $100 per long ton change in sulfur prices represents an estimated $35 million annualized cost impact. Second, management expects tighter domestic ammonium sulfate supply and improved demand in the first half of 2027, which could support Plant Nutrients volumes. Third, the company is progressing growth initiatives including the SUSTAIN ammonium sulfate project and Project CENTURY, backed by a $47 million USDA FIELDS grant. Finally, the company expects full-year 2026 capital expenditures of approximately $90 million and an effective tax rate of about 20%, while its new five-year, $425 million credit facility provides additional financial flexibility.
Integrating AI Tools Into My Analysis
In my own work, I often turn to Tickeron’s AI Screener when evaluating names like ASIX alongside peers. The tool helps me quickly filter for technical patterns, fundamentals, and industry trends, which adds useful context beyond the headline numbers and supports more informed watchlist building.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
ASIX's RSI Indicator recovers from oversold territory
The RSI Indicator for ASIX moved out of oversold territory on October 30, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 40 similar instances when the indicator left oversold territory. In 31 of the 40 cases the stock moved higher. This puts the odds of a move higher at 77%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 41 of 64 cases where ASIX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 64%.
Following a +1.43% 3-day Advance, the price is estimated to grow further. Considering data from situations where ASIX advanced for three days, in 196 of 300 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
ASIX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 19, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ASIX as a result. In 60 of 73 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.
The Moving Average Convergence Divergence Histogram (MACD) for ASIX turned negative on October 21, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 32 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 73%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ASIX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
The Aroon Indicator for ASIX entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 15 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.528) is normal, around the industry mean (1.204). ASIX has a moderately low P/E Ratio (-23.254) as compared to the industry average of (3.574). Projected Growth (PEG Ratio) (0.030) is also within normal values, averaging (3.769). Dividend Yield (0.041) settles around the average of (0.181) among similar stocks. P/S Ratio (0.290) is also within normal values, averaging (0.578).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 74 (best 1 - 100 worst), indicating slightly worse than average price growth. ASIX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ASIX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of polymer resins and chemicals
Industry ChemicalsMajorDiversified
Advertisement